Skip to content
DefDex

Federal award

QUIDELORTHO SALES COMPANY, LLC

W81K0223P0125

Contract

Obligated and Ceiling

Obligated (net)
$505,847.20
Ceiling (potential value, not spending)
$674,367.19
Current value
$674,367.19
Gross positive obligations
$506,499.93

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
Awarding agency
Department of War · sub-agency 97DH · office HT9410
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0223P0125
Award type code
B
Actions
11 · Sep 22, 2023 to Jun 10, 2026
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History11

Award actions
DateFYModAction typeObligationCompany in company totals
Jun 10, 2026FY2026P00010B$0.00
—
Apr 9, 2026FY2026P00009M$0.00
—
Mar 24, 2026FY2026P00008M$0.00
—
Dec 30, 2025FY2026P00007C$168,833.31
—
Nov 20, 2025FY2026P00006J$0.00
—
Jun 10, 2025FY2025P00005G$0.00
—
Feb 20, 2025FY2025P00004B−$652.73
—
Oct 29, 2024FY2025P00003C$168,833.31
—
Apr 22, 2024FY2024P00002G$0.00
—
Oct 19, 2023FY2024P00001C$168,833.31
—
Sep 22, 2023FY20230—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.